These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 15010862)
21. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome]. Chu YL; Sun YY; Qiu HY; Li HF Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378 [TBL] [Abstract][Full Text] [Related]
22. [Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome]. Wang ZC; Gu XF; Yang DZ; Kuang JQ Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):120-3. PubMed ID: 15840294 [TBL] [Abstract][Full Text] [Related]
23. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling. Sun H; Tu X; Liu M; Baserga R J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674 [TBL] [Abstract][Full Text] [Related]
24. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316 [TBL] [Abstract][Full Text] [Related]
26. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome. Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389 [TBL] [Abstract][Full Text] [Related]
27. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine. Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924 [TBL] [Abstract][Full Text] [Related]
28. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells. He S; Dibas A; Yorio T; Prasanna G Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470 [TBL] [Abstract][Full Text] [Related]
29. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. Marek L; Levresse V; Amura C; Zentrich E; Van Putten V; Nemenoff RA; Heasley LE J Cell Physiol; 2004 Dec; 201(3):459-69. PubMed ID: 15389548 [TBL] [Abstract][Full Text] [Related]
30. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients. Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987 [TBL] [Abstract][Full Text] [Related]
31. Annexin A6 inhibits Ras signalling in breast cancer cells. Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003 [TBL] [Abstract][Full Text] [Related]
32. Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients. Rapoport MJ; Mor A; Amit M; Rosenberg R; Ramot Y; Mizrachi A; Wysenbeek AJ Lupus; 1999; 8(1):24-8. PubMed ID: 10025596 [TBL] [Abstract][Full Text] [Related]
33. [P21ras--a central cross-road on intracellular signalling]. Levy O; Ramot Y; Rapoport M Harefuah; 1997 Oct; 133(7-8):304-8. PubMed ID: 9418364 [No Abstract] [Full Text] [Related]
34. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. Diks SH; Kok K; O'Toole T; Hommes DW; van Dijken P; Joore J; Peppelenbosch MP J Biol Chem; 2004 Nov; 279(47):49206-13. PubMed ID: 15355981 [TBL] [Abstract][Full Text] [Related]
35. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. Confino-Cohen R; Aharoni D; Goldberg A; Gurevitch I; Buchs A; Weiss M; Weissgarten J; Rapoport MJ J Allergy Clin Immunol; 2002 Feb; 109(2):349-56. PubMed ID: 11842308 [TBL] [Abstract][Full Text] [Related]
36. Constitutive up-regulated activity of MAP kinase is associated with down-regulated early p21Ras pathway in lymphocytes of SLE patients. Rapoport MJ; Amit M; Aharoni D; Weiss M; Weissgarten J; Bruck N; Buchs A; Bistritzer T; Molad Y J Autoimmun; 2002; 19(1-2):63-70. PubMed ID: 12367560 [TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia. Gallagher A; Padua RA; al-Sabah A; Hoy T; Burnett AK; Darley RL Leukemia; 1995 Nov; 9(11):1833-40. PubMed ID: 7475271 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex. Grewal T; Enrich C Bioessays; 2006 Dec; 28(12):1211-20. PubMed ID: 17120209 [TBL] [Abstract][Full Text] [Related]
39. Normal p21Ras/MAP kinase pathway expression and function in PBMC from patients with polycystic ovary disease. Buchs A; Chagag P; Weiss M; Kish E; Levinson R; Aharoni D; Rapoport MJ Int J Mol Med; 2004 Apr; 13(4):595-9. PubMed ID: 15010862 [TBL] [Abstract][Full Text] [Related]